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Because naı ¨ve T cells are unable to import cystine due to the absence of cystine transporters, it has been
suggested that T cell activation is dependent on cysteine generated by antigen presenting cells. The aim of
this study was to determine at which phases during T cell activation exogenous cystine/cysteine is required
andhowTcellsmeetthisrequirement.WefoundthatearlyactivationofTcellsisindependentofexogenous
cystine/cysteine, whereas T cell proliferation is strictly dependent of uptake of exogenous cystine/cysteine.
Naı ¨veTcellsexpressnoorverylow levelsofbothcystineandcysteinetransporters. However,wefoundthat
these transporters become strongly up-regulated during T cell activation and provide activated T cells with
the required amount of cystine/cysteine needed for T cell proliferation. Thus, T cells are equipped with
mechanisms that allow T cell activation and proliferation independently of cysteine generated by antigen
presenting cells.
T
he tripeptide glutathione (GSH) is a ubiquitous intracellular peptide with diverse functions that include
antioxidantdefense,maintenanceofthiolstatus,andmodulationofcellproliferation.GSHplaysanessential
role in T cell function, and several studies have found that an increase in intracellular GSH during T cell
activation is required for T cell proliferation
1–4. GSH is synthesized in the cytosol in a tightly regulated manner
withcysteine(Cys)beingtherate-limitingaminoacid
5.Theoretically,TcellscanobtainCyseitherbytransportof
Cys or the oxidized, dimeric form of Cys called cystine (Cys2) from the extracellular space or by endogenous
production of Cys from methionine (Met) via the transsulfuration pathway
6. Whether the transsulfuration
pathway actually exists in T cells is controversial. Some studies support the presence of the transsulfuration
pathway in T cells
6,7 whereas other studies have concluded that T cells lack this pathway
8,9.
Due to the oxidizing environment approximately 90% of Cys is found as oxidized Cys2 in the extracellular
space. Thus, plasma contains 50 – 100 mM Cys2, whereas the concentration of Cys is very low compared to other
amino acids
10,11. Cys is transported over the plasma membrane predominantly by the neutral amino acid trans-
porters ASCT1 and ASCT2, whereas Cys2 exclusively is transported by the xc
2 cystine/glutamate antiporter
12,13.
ImportedCys2israpidlyreducedtoCysinthecytosolduetothereducingintracellularmilieu.Bymeasurementof
the uptake of Cys and Cys2 previous studies have indirectly indicated that T cells express ASCT1 and/or ASCT2
transporters but not xc
214,15. Based on these observations it was suggested that a sufficient high concentration of
exogenous Cys in the microenvironment is provided to T cells by activated antigen presenting cells (APC), and
that this APC-generated Cys is required for T cell activation
16,17. Recently, it was confirmed that naı ¨ve unstimu-
lated T cells do not express the xc
2 cystine/glutamate antiporter but interestingly it was also found that T cell
activation induced the expression of xc
26,18. This indicated that T cells are released from their need for APC-
generated Cys early after activation, and it was suggested that APC-generated Cys is essential to start T cell
activation
18. Thus, the model predicted that in the early phases of an immune response APC nurse T cells by
takingupoxidizedCys2andreleasingCys.ThereleasedCysistheninternalizedbythenaı ¨veTcellsviatheirASCT
transporters. Later on, the activated T cells can meet their requirement for Cys by uptake of Cys2 via the induced
expression of xc
2 and thereby become independent of Cys generated by the APC
19,20. However, the proposed
dependency on APC-generated Cys for early T cell activation is in conflict with other studies demonstrating that
purified T cells can be fully activated in the absence of APC
4,21. The aim of this study was to determine at which
phases during activation of purified T cells Cys is required and how T cells can meet this requirement. We found
that early T cell activation as measured by CD25 and CD69 expression and secretion of IL-2 was independent of
Cys, whereas T cell proliferation was strictly dependent on Cys. T cell activation led to a strong up-regulation of
boththeCys2transporterxc
2andtheCystransportersASCT1andASCT2independentlyofCys.TheTcellsmet
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importing either Cys2 or Cys via the activation-induced xc
2,
ASCT1 and ASCT2 transporters.
Results
Early T cell activation is independent of Cys and Met whereas
T cell proliferation is strictly dependent on Cys. To study a
homogeneous population of T cells we purified antigen-
inexperienced naı ¨ve CD4
1 T cells from blood samples obtained
from healthy blood donors. The resulting cell population consisted
of,98%CD4
1,CD45RA
1,CD25
2,CD69
2Tcells(Supplementary
Fig. 1S). To study the requirements of T cell activation for Cys and
Met westimulated the purified Tcells with anti-CD3 and anti-CD28
coated Dynabeads in Cys- and Met-free medium that was either not
supplemented or supplemented with Met, Cys2, or a combination of
the two. We found that early T cell activation as measured by CD25
and CD69 expression was independent of Cys2 and Met, although
the CD25 expression was somewhat higher in cells stimulated
in medium supplemented with Cys2 (Fig. 1 A–D). Likewise, IL-2
production was independent of Cys2 and Met (Fig. 1 E & F).
In contrast, T cell proliferation as measured by
3H-thymidine
incorporation was strictly dependent on Cys2 and was optimal in
the presence of both Cys2 and Met (Fig. 1G). To determine the
minimal concentrations of Cys2 and Met required for optimal T
cell proliferation we next performed a checkerboard titration of
Cys2 and Met. We found that the minimal concentrations of Cys2
andMetrequiredforoptimalTcellproliferationwere66and33mM,
respectively (Fig. 1H). Thus, the normal plasma Cys2 concentration
of 50 – 100 mM seems to fully satisfy the Cys2 requirement for T cell
proliferation. In the absence of Cys2, T cell proliferation did not take
placeirrespectiveoftheMetconcentrationstested.Incontrast,inthe
absence of Met, supplementation of the medium with just 22 mMo f
Cys2 resulted in significant T cell proliferation (Fig. 1H).
Activated T cells strongly up-regulate transporters for Cys2 and
Cys. The experiments described above demonstrated that early
T cell activation is independent of Cys and Met, whereas T cell
proliferation is strictly dependent on Cys. This indicated that
T cells have or obtain the ability to transport Cys2 and/or Cys over
the plasma membrane during their activation. Furthermore, the
experiments demonstrated that if T cells possess the transsulfura-
tionpathwaythisisnotefficientenoughtocovertherequirementfor
Cys during T cell proliferation. The xc
2 cystine/glutamate antiporter
that transport Cys2 over the plasma membrane is a disulfide-bonded
heterodimer composed of the heavy subunit 4F2hc (CD98) and the
light subunit xCT (gene name SLC7A11)
13. CD98 is involved in
trafficking of the heterodimer to the plasma membrane, whereas
xCT confers specificity for Cys2. CD98 acts as a subunit for various
amino acid transporters and is therefore commonly expressed.
Whereas xc
2 is the only known transporter for Cys2, several
transporters for Cys exist, the most important being the neutral
amino acid transporters ASCT1 (gene name SLC1A4) and ASCT2
(gene name SLC1A5)
22,23. To determine the expression level of xc
2,
ASCT1 and ASCT2 on CD4
1 T cells we stimulated the cells for zero
to72 hoursinX-VIVO15mediumandmeasuredthelevelofprotein
and gene expression for these transporters. We found that un-
stimulated naı ¨ve CD4
1 T cells express no or very low levels of
xCT and ASCT2 as determined by Western blot analyses (Fig. 2A).
We could not determine the protein level of ASCT1 as no proper
anti-ASCT1 antibodies were available for the use in Western blot
analyses. T cell stimulation induced strong up-regulation of both
xCT and ASCT2 (Fig. 2A). In agreement, gene expression analyses
demonstrated that the transporter genes were weakly expressed in
naı ¨ve T cells and that they became strongly up-regulated following
T cell activation (Fig. 2B & C). In particular the gene for xCT was
up-regulated approximately 500 fold relative to the housekeeping
gene GAPDH (Fig. 2C). In concordance with this, we found a
significant up-regulation of CD98 as measured by FACS analysis
(Fig. 2D).
Both the xc
- cystine/glutamate antiporter and the neutral amino
acid transporters can supply T cells with the required amounts of
Cys. The above studies demonstrated that CD4
1 T cells start to
express high levels of both Cys2 and Cys transporters following
activation. Due to the oxidizing environment the vast majority of
Cys is found as oxidized Cys2 in the extracellular space and in most
cell growth media; however, approximately 10% is found as Cys in
these sites
10. To determine whether T cells predominantly meet their
Cys requirement by uptake of Cys2 or by uptake of Cys we inhibited
the uptake of Cys2 by incubation of the cells in X-VIVO 15 medium
supplemented with increasing quantities of glutamic acid (Glu).
Glu is the main exchange substrate in the xc
2 cystine/glutamate
antiporter-mediated uptake of Cys2 and is a highly specific
inhibitor of Cys2 uptake
13. We found that incubation of the cells
with 20 mM of Glu inhibited T cell proliferation by more than
90% (Fig. 3A). This indicated that T cell proliferation is dependent
on the uptake of Cys2 via the xc
2 cystine/glutamate antiporter. To
exclude the possibility that the observed inhibition of T cell
proliferation was caused by toxic side effects of Glu, and to test
whether the neutral amino acid transporters could substitute for
the xc
2 transporter we incubated the cells in X-VIVO 15 medium
with a fixed concentration of Glu (20 mM) in combination with
increasing quantities of 2-mercaptoethanol (2-ME), which reduces
the Cys2 in the medium to Cys. Thus, if the cells were unaffected by
thehighGluconcentrationandiftheneutralaminoacidtransporters
were functional, T cell proliferation should be reconstituted with
increasing concentrations of 2-ME. Indeed, we found that 2-ME
reconstituted T cell proliferation and that T cell proliferation could
becompletelyrescuedbyadding2-MEataconcentrationof50–100
mM (Fig. 3B). Likewise, supplementation of X-VIVO 15 medium
containing 20 mM Glu with free thiols in the form of N-acetyl-
L-cysteine or with GSH completely rescued T cell proliferation
(Supplementary Fig. 2S). Thus, during normal conditions T cell
proliferation is strictly dependent on xc
2 -mediated uptake of Cys2.
However, if Cys is present in sufficiently high concentrations in the
extracellular environment ASCT1 and ASCT2 can provide adequate
Cys uptake required for T cell proliferation.
To further study the need for Cys during T cell activation we
stimulated the cells in X-VIVO 15 medium supplemented with
increasing quantities of Glu and measured the expression of the
activation markers CD25, CD62L, CD69 and CD98 by FACS. We
found that even Glu concentrations that completely abolished T cell
proliferation did not affect the expression of the activation markers
(Fig. 3C). Neither did Glu inhibit expression of the activation-
induced xCT, ASCT1 and ASCT2 transporters (Fig. 3D). These
experiments confirmed that early T cell activation, including the
up-regulation of the Cys2 and Cys transporters, is independent of
Cys, whereas T cell proliferation is strictly dependent on Cys.
Discussion
Inthisstudy wedemonstrate thathuman naı ¨ve CD4
1Tcellsexpress
no or very low levels of the Cys2 transporter xc
2 and the Cys trans-
porters ASCT1 and ASCT2, and that the expression of these trans-
porters is strongly up-regulated during T cell activation. This is the
first study that directly measures the expression of ASCT1 and
ASCT2 on human T cells. Concerning expression of ASCT1 and
ASCT2, our results are in good agreement with previous studies,
which found that the potential of resting T cells to take up Cys was
very low and that it increased significantly following T cell activa-
tion
14,15,24.Concerningexpressionofxc
2onTcells,conflictingresults
have been reported. Based on measurements of Cys2 uptake and the
potentialofGlutoinhibitCys2uptake,somestudiesindirectlyfound
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 266 | DOI: 10.1038/srep00266 2Figure 1 | Early T cell activation is independent of Cys and Met whereas T cell proliferation is strictly dependent on Cys. Purified naı ¨ve CD4
1 T cells
wereincubatedinMet-andCys-freeDMEMmediumwithoutstimulation(blackcolumnsandlinesinA–G)orwerestimulatedwithDynabeadsHuman
T-Activator CD3/CD28 in Met- and Cys-free DMEM medium (red columns and lines in A–G) or in Met- and Cys-free DMEM medium supplemented
witheither33 mM Met(bluecolumnsandlinesinA–G), 66mMCys2(orangecolumns andlinesinA–G),or 33 mMMetplus66 mMCys2(green columns
and lines in A–G). The expression levels of CD25 and CD69 were determined by flow cytometry after 24 hours of cell culture and depicted as mean
fluorescenceintensity(MFI)(AandC)andasFACSprofiles(BandD).TheproductionofIL-2wasmeasuredbyELISAfollowing24(E)and48(F)hours
of cell culture. T cell proliferation was measured as
3H-thymidine incorporation for the last six hours of a total of 72 hours of cell culture (G and H). The
results shown are representative for at least three separate experiments.
www.nature.com/scientificreports
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2 on both resting and acti-
vated T cells
14,15. However, the Glu concentrations used in these
studies to inhibit xc
2 were quite low (0.5 – 2.5 mM), and in one of
thestudiesuptakeofCys2wasactuallyobservedinrestingTcellsand
it increased by a factor three in activated T cells
14. Another study
found indirect evidence for xc
2 expression on activated T cells by
observing Glu-mediated inhibition of T cell proliferation
25. In agree-
ment with our findings, recent studies have found that xc
2 is not
expressed on resting T cells but becomes expressed following T cell
activation
6,18. Based on these and our study we believe that it can be
concluded that naı ¨ve T cell express no or very low levels of xc
2,
ASCT1 and ASCT2, and that the expression of these transporters
is strongly induced during T cell activation. In agreement with this,
we found that early T cell activation is independent of Cys and
thereby of Cys2 and Cys uptake via xc
2, ASCT1 and ASCT2 trans-
porters thatthe Tcells donotexpress atthis early stage of activation.
Figure 2 | Activated T cells strongly up-regulate the xc
2 cystine/glutamate antiporter and the neutral amino acid transporters ASCT1 and ASCT2.
Purified naı ¨ve CD4
1 T cells were incubated in X-VIVO 15 medium and stimulated with Dynabeads Human T-Activator CD3/CD28 for the time
indicated. The cells were harvested and the expression of xCT (55 and 35 kDa
31) and ASCT2 (75 kDa) was determined by Western blot analyses using
TCRf (16 kDa) as loading control (A) or by quantitative RT-PCR (B and C). The gene expression levels of the target genes are given relative to the
housekeepinggeneGAPDH(B)orasfoldincreaseofthetargetgeneexpressionrelativetoGAPDH(C).CD98expressionwasmeasuredbyFACSanalyses
following zero (black line), 24 (red line) and 48 (blue line) hours of cell culture (D). The results shown are representative for at least two separate
experiments.
www.nature.com/scientificreports
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isstrictlydependentonCys.Thisisingoodagreementwithprevious
studies, which found that T cell proliferation, specifically the pro-
gression from G1 of the cell cycle to the S phase, is dependent on an
increased GSH synthesis in which Cys is the rate-limiting amino
acid
2–5. The increased production and translocation of GSH into
the cell nucleus probably provides the reducing power required for
the generation of dNTPs for DNA synthesis
26,27.
At first sight it might seem puzzling that activated T cells can
synthesize proteins like the activation markers, the Cys and Cys2
transporters and IL-2 reported in this study in the absence of exo-
genous Met, Cys and Cys2. However, the amino acids required for
protein synthesis is probably provided from a combination of (i) the
intracellularaminoacidpool,(ii) proteincatabolism, and(iii)degra-
dationofGSH.IthasbeenreportedthatrestingTcellscontainapool
of GSH that is rapidly degraded
2,14 and rebuild probably via the c-
glutamyl cycle
28,29. Degraded GSH might be an important source of
Cys. Fundamentally different pathways are used by cells for protein
versusGSHsynthesis,anditispossiblethatduringCysscarcityGSH
rebuilding is minimized in favor of protein synthesis.
In theory, T cells can also obtain Cys through the conversion of
Met to Cys via the transsulfuration pathway
6. However, we found
that Cys could not be substituted by Met in T cell proliferation, and
we conclude that if the transsulfuration pathway actually exists in T
cells as previously suggested
6,7, it cannot supply the T cells with the
amount of Cys needed for T cell proliferation to take place.
It has been postulated that naı ¨ve T cells are metabolically depend-
ent on APC to meet their Cys requirements because Cys is the least
abundant of the amino acids in the extracellular space and naı ¨ve
T cells are unable to import Cys2 due to the absence of xc
26,16–20.
However, we found that early activation of naı ¨ve T cells including
expression of activation markers, Cys and Cys2 transporters and
production of IL-2 is not dependent on Cys. Furthermore, we show
that in addition to xc
2, activated T cells express ASCT1 and ASCT2,
and we present evidence that both the Cys2 and Cys transporters are
functional transporters, which can provide T cells with the required
amount of Cys needed for T cell proliferation. Thus, human naı ¨ve
CD4
1 T cells are fully equipped with mechanisms that allow T cell
activation and proliferation independently of cysteine generated by
antigen presenting cells.
Methods
Cells and reagents. Blood mononuclear cells were isolated by density gradient
centrifugation using Lymphoprep (Nycomed, Roskilde, Denmark). Naı ¨ve CD4
1
T cells were subsequently isolated by negative selection using the naı ¨ve CD4
1
T cell isolation kit II (cat. no. 130-094-131, Miltenyi Biotec GmbH, Bergisch
Gladbach, Germany) according to the manufacturer. The purified T cells were
cultured in either Dulbecco’s Modified Eagle Medium without L-methionine and
L-cystine (cat. no. 21013, Invitrogen, Paisly, UK) or in X-VIVO 15 medium
(cat. no. 1041, Lonza, Verviers, Belgium) that contains Cys2 and Met at 290 and 200
mM, respectively. The cells were stimulated with Dynabeads Human T-Activator
CD3/CD28 (cat. no. 111.31D, Invitrogen) at 37uCi n5 %C O 2 at a cell concentration
of 0.25 – 1.0310
6 cells/ml for the times indicated at a bead to cell ratio of two to five.
L-methionine (M5308), L-cystine dihydrochloride (C6727), L-glutamic acid
Figure 3 | Both the xc
2 cystine/glutamate antiporter and the neutral amino acid transporters can supply T cells with the required amounts of Cys. (A
and C) Purified naı ¨ve CD4
1 T cells were incubated in X-VIVO 15 medium supplemented with the indicated concentrations of Glu and stimulated with
Dynabeads Human T-Activator CD3/CD28 for 72 h(A) or 48 h (C). Tcell proliferation wasmeasured by incorporation of
3H-thymidine for the last 6 h
ofcellculture(A).TheexpressionlevelsofactivationmarkersweremeasuredbyFACSanalyses(C).(B)Purifiednaı ¨veCD4
1TcellswereincubatedinX-
VIVO 15 medium supplemented with 20 mM of Glu and the indicated concentrations of 2-ME and stimulated with Dynabeads Human T-Activator
CD3/CD28 for 72 h. T cell proliferation was measured by incorporation of
3H-thymidine for the last 6 h of incubation. (D) Purified naı ¨ve CD4
1 T cells
were incubated in X-VIVO 15 medium that was either not supplemented (lane 1) or supplemented with 20 mM of Glu (lane 2) and stimulated with
DynabeadsHumanT-ActivatorCD3/CD28for72 h.TheexpressionofxCTandASCT2wasdetermined byWesternblotanalysesusingTCRfasloading
control. The results shown in A and B represent mean values 6 SEM of triplicates determinations and are representative for three separate experiments.
The results shown in C and D are representative for two separate experiments.
www.nature.com/scientificreports
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Aldrich (Brondby, Denmark).
Flow cytometry and Western blot analysis. To determine the expression levels of
various surface markers we incubated the cells with fluorochrome-conjugated anti-
CD4 (clone SK3), anti-CD25 (clone 2A3), anti-CD45RA (clone HI100), anti-CD62L
(clone Dreg 56), anti-CD69 (clone L78) or anti-CD98 (clone UM7F8) monoclonal
antibodies all from BDBiosciences (San Diego, CA). The cells were subsequently run
on a FACSCalibur (BD Biosciences). Data analysis was performed using FlowJo
software (Tree Star, Ashland, OR, USA). For Western blot analyses cells were
stimulated with Dynabeads Human T-Activator CD3/CD28 for the time indicated at
37uC, lysed in lysis buffer (50 mM Tris-Base pH 7.5, 150 mM NaCl, 1 mM Mg2Cl)
supplemented with 1% Triton X-100, 1 mg/ml Pefabloc SC, 10 mg/ml Leupeptin, 10
mg/mlPepstatinand5 mMEDTAandrunon10%polyacrylamidegels.Theproteins
were transferred to Amersham Hybond ECL nitrocellulose sheets (GE Healthcare,
Brondby, Denmark) and visualized by anti-xCT (cat. no NB300-318, Novus
Biologicals,Littleton,CO,USA),anti-ASCT2(cloneG11,CellSignaling,Technology,
Danvers, MA, USA) or anti-TCRf (clone 6B10.2, Santa Cruz Biotechnology, Santa
Cruz, CA) antibodies followed by either HRP-swine anti-rabbit Ig or HRP-rabbit
anti-mouse Ig (cat. no. P0399 and P0260, Dako, Glostrup, Denmark) using
Amersham ECL technology (GE Healthcare).
Quantitative RT-PCR analysis. To quantify gene expression we used reversed
transcriptioncombinedwiththepolymerasechainreaction(RT-PCR)method.Total
RNA was isolated from purified naı ¨ve CD4
1 T cells or stimulated CD4
1 T cells. One
mg of the total RNA from each sample was reverse-transcribed into cDNA using
RevertAid
TM First Strand cDNA Synthesis Kit (cat. no. K1621, Fermentas GmbH, St.
Leon-Rot, Germany). The amount of xCT (SLC7A11), ASCT1 (SLC1A4), ASCT2
(SLC1A5) and GAPDH mRNA was determined by using primers from TAG
Copenhagen and Stratagene Brilliant SYBRH Green QPCR Master Mix (Agilent
Technologies, Horsholm, Denmark). A PCR amplification profile was derived by
recording the SYBR Green fluorescence intensity, which was in linear relation to the
amount of formed PCR product as a function of PCR cycle number. The SLC7A11,
SLC1A4 and SLC1A5 mRNAs were calculated relative to the GAPDH housekeeping
geneandnormalizedtocontrolconditionsbyusingthe2
2DDCtmethod
30.Weusedthe
following primers: xCT- forward 59-GCT GTG ATA TCC CTG GCA TT-39, xCT-
reverse 59-CAG AAT TGC TGT GAG CTT GC-39, ASCT1 59-ATT GGT CCT GTT
TGCTCTGG-39,ASCT1reverse59-TGGGGAGAATAAACCTGCTG-39,ASCT2
forward 59-TAC ATT CTG TGC TGC CTG CT-39, ASCT2 reverse 59-ATG AAA
CGG CTGATG TGC TT-39, GAPDH forward 59-AAG GTG AAG GTC GGA GTC
AA-39 and GAPDH reverse 59-AAT GAA GGG GTC ATT GAT GG-39.
1. Hamilos,D.L.&Wedner,H.J.Theroleofglutathioneinlymphocyteactivation.I.
Comparisonofinhibitoryeffectsofbuthioninesulfoximineand2-cyclohexene-1-
one by nuclear size transformation. J. Immunol. 135, 2740–2747 (1985).
2. Hamilos, D. L., Zelarney, P. & Mascali, J. J. Lymphocyte proliferation in
glutathione-depleted lymphocytes: direct relationship between glutathione
availability and the proliferative response. Immunopharmacology 18, 223–235
(1989).
3. Messina, J. P. & Lawrence, D. A. Cell cycle progression of glutathione-depleted
human peripheral blood mononuclear cells is inhibited at S phase. J. Immunol.
143, 1974–1981 (1989).
4. Suthanthiran, M., Anderson, M. E., Sharma, V. K. & Meister, A. Glutathione
regulates activation-dependent DNA synthesis in highly purified normal human
TlymphocytesstimulatedviatheCD2andCD3antigens.Proc.Natl.Acad.Sci.U.
S. A 87, 3343–3347 (1990).
5. Lu, S. C. Regulation of glutathione synthesis. Mol. Aspects Med. 30, 42–59 (2009).
6. Garg, S. K., Yan, Z., Vitvitsky, V. & Banerjee, R. Differential dependence on
cysteinefromtranssulfurationversustransportduringTcellactivation.Antioxid.
Redox. Signal. 15, 39–47 (2011).
7. Sturman, J. A., Beratis, N. G., Guarini, L. & Gaull, G. E. Transsulfuration by
human long term lymphoid lines. Normal and cystathionase-deficient cells. J.
Biol. Chem. 255, 4763–4765 (1980).
8. Eagle, H., Washington, C. & Friedman, S. M. The synthesis of homocystine,
cystathionine, and cystine by cultured diploid and heteroploid human cells. Proc.
Natl. Acad. Sci. U. S. A 56, 156–163 (1966).
9. Srivastava,M. K., Sinha, P., Clements, V. K., Rodriguez, P. & Ostrand-Rosenberg,
S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine
and cysteine. Cancer Res. 70, 68–77 (2010).
10. Saetre, R. & Rabenstein, D. L. Determination of cysteine in plasma and urine and
homocysteineinplasmabyhigh-pressureliquidchromatography.Anal.Biochem.
90, 684–692 (1978).
11. Hack, V. et al. Cystine levels, cystine flux, and protein catabolism in cancer
cachexia, HIV/SIV infection, and senescence. FASEB J. 11, 84–92 (1997).
12. Kanai, Y. & Hediger, M. A. The glutamate/neutral amino acid transporter family
SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch. 447,
469–479 (2004).
13. Lo, M., Wang, Y. Z. & Gout, P. W. The x(c)- cystine/glutamate antiporter: a
potential target for therapy of cancer and other diseases. J. Cell Physiol 215, 593–
602 (2008).
14. Ishii, T., Sugita, Y. & Bannai, S. Regulation of glutathione levels in mouse spleen
lymphocytes by transport of cysteine. J Cell Physiol 133, 330–336 (1987).
15.Gmunder,H.,Eck,H.P.&Droge,W.Lowmembranetransportactivityforcystine
in resting and mitogenically stimulated human lymphocyte preparations and
human T cell clones. Eur. J. Biochem. 201, 113–117 (1991).
16. Angelini, G. et al. Antigen-presenting dendritic cells provide the reducing
extracellularmicroenvironmentrequired forTlymphocyte activation. Proc. Natl.
Acad. Sci. U. S. A 99, 1491–1496 (2002).
17. Yan, Z., Garg, S. K., Kipnis, J. & Banerjee, R. Extracellular redox modulation by
regulatory T cells. Nat. Chem. Biol. 5, 721–723 (2009).
18. Castellani, P., Angelini, G., Delfino, L., Matucci, A. & Rubartelli, A. The thiol
redox state of lymphoid organs is modified by immunization: role of different
immune cell populations. Eur. J Immunol 38, 2419–2425 (2008).
19. Rubartelli, A. & Sitia, R. Chemo-metabolic regulation of immune responses by
Tregs. Nat. Chem. Biol. 5, 709–710 (2009).
20. Yan, Z. & Banerjee, R. Redox remodeling as an immunoregulatory strategy.
Biochemistry 49, 1059–1066 (2010).
21. von Essen, M. R. et al. Vitamin D controls T cell antigen receptor signaling and
activation of human T cells. Nat. Immunol. 11, 344–349 (2010).
22. Broer, S. Amino acid transport across mammalian intestinal and renal epithelia.
Physiol Rev. 88, 249–286 (2008).
23. Kanai, Y. & Hediger, M. A. The glutamate and neutral amino acid transporter
family: physiological and pharmacological implications. Eur. J. Pharmacol. 479,
237–247 (2003).
24. Borghetti, A. F., Tramacere, M., Ghiringhelli, P., Severini, A. & Kay, J. E. Amino
acid transport in pig lymphocytes. Enhanced activity of transport system asc
following mitogenic stimulation. Biochim. Biophys. Acta 646, 218–230 (1981).
25. Lombardi, G., Dianzani, C., Miglio, G., Canonico, P. L. & Fantozzi, R.
Characterization of ionotropic glutamate receptors in human lymphocytes. Br. J.
Pharmacol. 133, 936–944 (2001).
26. Markovic, J. et al. Glutathione is recruited into the nucleus in early phases of cell
proliferation. J. Biol. Chem. 282, 20416–20424 (2007).
27. Zahedi, A. F. & Holmgren, A. Molecular mechanisms of thioredoxin and
glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide
reductase. J. Biol. Chem. 284, 8233–8240 (2009).
28. Orlowski, M. & Meister, A. The gamma-glutamyl cycle: a possible transport
system for amino acids. Proc. Natl. Acad. Sci. U. S. A 67, 1248–1255 (1970).
29. Wu, G., Fang, Y. Z., Yang, S., Lupton, J. R. & Turner, N. D. Glutathione
metabolism and its implications for health. J. Nutr. 134, 489–492 (2004).
30. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using
real-time quantitative PCR and the 2
2DDCt method. Methods 25, 402–408 (2001).
31. Shih, A. Y. et al. Cystine/glutamate exchange modulates glutathione supply for
neuroprotection from oxidative stress and cell proliferation. J. Neurosci. 26,
10514–10523 (2006).
Acknowledgements
ThisworkwassupportedbygrantsfromTheDanishMedicalResearchCoun-cil,TheNovo
Nordisk Foundation, The Lundbeck Foundation, The A.P. Møller Foundation for the
Advancement of Medical Sciences, and Lægeforeningens Forskningsfond.
Author contributions statement
Conceived and designed the experiments: CG, AKH, TBL, MRvE, CMB, AW, NØ.
Performed the experiments: TBL, BLN, AKH, MK. Analyzed the data: CG, TBL, AKH,
CMB, AW, NØ. Wrote the paper: CG, TBL.
Additional information
Supplementary information accompanies this paper at http://www.nature.com/
scientificreports
Competing financial interests: The authors declare no competing financial interests.
License: This work is licensed under a Creative Commons
Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this
license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
How to cite this article: Levring, T.B. et al. Activated human CD4
1 T cells express
transporters for both cysteine and cystine. Sci. Rep. 2, 266; DOI:10.1038/srep00266 (2012).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 266 | DOI: 10.1038/srep00266 6